A relaxin-based nanotherapy for liver fibrosis
Source abstract
Abstract
Targeting of the peptide hormone relaxin to injured mouse liver, via a nanoparticle/gene therapy approach, switches pro-fibrotic hepatic macrophages to a restorative phenotype that orchestrates tissue repair.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Pregnancy-related medical research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (12)
Show source-provided references
1. Hu, M. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-020-00836-6 (2020).10.1038/s41565-020-00836-6 ↗
2. Samuel, C. S. et al. Ann. N. Y. Acad. Sci. 1041, 173–81 (2005).10.1196/annals.1282.025 ↗
3. Fallowfield, J. A. et al. Hepatology 59, 1492–1504 (2014).10.1002/hep.26627 ↗
4. Lee, K.-C. et al. Lab. Investig. 99, 1203–1216 (2019).10.1038/s41374-019-0240-y ↗
5. Bennett, R. G., Heimann, D. G., Singh, S., Simpson, R. L. & Tuma, D. J. Liver Int. 34, 416–426 (2014).10.1111/liv.12247 ↗
6. Kaftanovskaya, E. M. et al. FASEB J. 33, 12435–12446 (2019).10.1096/fj.201901046R ↗
7. Kim, J. K. et al. J. Gene Med. 18, 16–26 (2016).10.1002/jgm.2872 ↗
8. Nagórniewicz, B. et al. Nanomedicine 17, 106–118 (2019).10.1016/j.nano.2018.12.008 ↗
9. Ramachandran, P. et al. Proc. Natl Acad. Sci. USA 109, E3186–E3195 (2012).10.1073/pnas.1119964109 ↗
10. Chen, L. et al. Oncotarget 8, 21044–21053 (2017).10.18632/oncotarget.15483 ↗
11. Ramachandran, P. et al. Nature 575, 512–518 (2019).10.1038/s41586-019-1631-3 ↗
12. Pellicoro, A., Ramachandran, P., Iredale, J. & Fallowfield, J. A. Nat. Rev. Immunol. 14, 181–194 (2014).10.1038/nri3623 ↗